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The heat shock response and the KEAP1/NRF2/ARE pathway are inducible defense systems that allow the cell to adapt and survive
under stress conditions. Zhang et al. found that structurally diverse inducers of the KEAP1/NRF2/ARE pathway, all of which react with
sulfhydryl groups, have a dual cytoprotective role by also activating the heat shock response, thus implicating the heat shock
response as a target for Nrf2 inducers. This newly uncovered duality contributes to the cytoprotective effects of such molecules
in models of carcinogenesis, cardiovascular disease, and neurodegeneration.
Aminoacylated tRNAs Hijackers
PAGE 1362
Cyclodipeptide synthases (CDPSs) are small enzymes structurally related to class-I aminoacyl-tRNA synthetases that hijack amino-
acylated tRNAs from their canonical role in ribosomal protein synthesis and use them for cyclodipeptide formation. Seguin et al. show
that a predicted protein identified in the sea anemoneNematostella vectensis,Nvec-CDPS2, is an active CDPS catalyzing the forma-
tion of various cyclodipeptides, thus representing the first enzyme involved in nonribosomal peptide synthesis to be identified in
animals.vi Chemistry & Biology 18, NoveArginylation and Methylation Go Hand in Hand
PAGE 1369
Protein arginylation and arginine methylation are two posttranslational modifications of emerging
importance that involve Arg. Saha et al. demonstrate that posttranslationally added arginines can
be further modified by methylation and that this double modification can regulate nuclear architec-
ture. This is exciting evidence that posttranslationally modified sites of proteins can undergo subse-
quent posttranslational modifications, establishing a functional link between protein arginylation and
Arg-methylation. It is likely that such double modifications can increase the complexity of the
signaling, exert many regulatory functions through a limited number of protein sites, and even
provide a unique type of protein code.
Synergizing with b-Lactam Antibiotics
PAGE 1379A chemical-genetic strategy was utilized to identify essential genes of methicillin resistant Staphylococcus aureus (MRSA) required
for antibiotic resistance. Lee et al. describe key chemical genetic interacting networks that restore antibiotic susceptibility to hospital-
and community-acquired MRSA. The authors provide a rational framework for developing inhibitors of targets within this chemical
genetic interaction network, which if paired with existing b-lactam antibiotics would display synergistic antibacterial activity and offer
a combination agent strategy to restore the efficacy of this important antibiotic drug class.
Reverse Cisplatin Resistance
PAGE 1390
Deubiquitinases (DUBs) represent a promising family of targets for new therapies of human cancers and neurological diseases.
Chen et al. discovered selective and cell-active inhibitors against human USP1/UAF1, a DUB complex involved in translesion
synthesis and DNA interstrand crosslink repair. The inhibitors reverse the chemoresistance of non-small cell lung cancer (NSCLC)
cells to cancer drug, cisplatin.
Accelerating Inhibitor Development for DUBs
PAGE 1401
Converting lead compounds into drug candidates is a crucial step in drug development, requiring early assessment of potency,
selectivity, and off-target effects. Altun et al. use activity-based chemical proteomics to determine the potency and selectivity of
deubiquitylating enzyme (DUB) inhibitors in cell culture models. The mass spectrometry based approach described here allows
direct target discovery of small molecular compounds in a cellular environment, providing important information on their mechanism
of action.
Leader Peptide Guiding the Biosynthesis
PAGE 1413
Microviridins are ribosomally produced unique protease inhibitors from bloom-forming cyanobacte-
ria that have both ecological and pharmacological relevance. Two ATP grasp ligases introduce
u-ester and u-amide bonds into the peptide backbone to yield rare cage-like structures. Weiz
et al. report the establishment of a minimal expression system for microviridins, characterize the
MdnA leader peptide, and identify a strictly conserved binding motif that is specific for microviridin
ligases. They further unveil that the ABC transporter MdnE is crucial for cyclization and processing of
microviridins and is essential for stability of the microviridin biosynthesis complex.mber 23, 2011 ª2011 Elsevier Ltd All rights reserved
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Priondiseasesare neurodegenerativedisorders characterizedby theprionprotein (PrP)misfolding andaccumulation in thebrain. PrP-
lipid interactions play a role during the misfolding process, and Sangher et al. now provide an atomic-level view of the complex
between theneuronal gangliosideGM1andPrP. TheGM1bindingepitopeonPrP involvesaminoacidspreviously suggested tomodu-
late prion proteinmisfolding and the new structural information will be useful for targeting of the complex by small molecule inhibitors.Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase
PAGE 1432
Themycobacterial biotin protein ligase (MtBPL) regulates lipid metabolism inMtb. Duckworth et al. have rationally designed a bisub-
strate inhibitor ofMtBPL, which displays potent subnanomolar enzyme inhibition and antitubercular activity. This inhibitor decreases
in vivo protein biotinylation of key enzymes involved in fatty acid biosynthesis and exhibits MtBPL-dependent antibacterial activity.
Collectively, the data suggest that MtBPL is a promising target for further antitubercular therapeutic development.From Natural Product Extracts to Active Compounds
PAGE 1442
The chemical diversity of nature has tremendous potential for discovery of new medicinal agents. However, the crude extracts con-
taining these molecules derived from plants and microorganisms can be difficult to test in current day drug discovery programs due
to accompanying pigments, salts, and polymers that interfere with sensitive biological assays. Furthermore, the concentration of
a particular chemical component may vary greatly, thus easily going undetected if tested below its effective concentration or appear-
ing overtly toxic if tested at high concentration. Cruz et al. now describe a method that avoids these pitfalls and rapidly identifies
natural products with promising activity.Self-Assembling Peptide Nanotubes Against HCV
PAGE 1453
An estimated 180 million people worldwide are infected with hepatitis C. No vaccine against hepatitis C is
currently available; therefore, there is an urgent need for new classes of anti-HCV drugs. In this study, Montero
et al. report a class of supramolecular agents specifically targeting HCV entry at a postbinding step. The
results suggest that these antiviral peptides can efficiently control viral spread in cell culture, making them
potential candidates for controlling spread of the infection in vivo, including restricting the spread of emerging
drug-resistant virus variants in combination therapy.Allosteric Regulation of PKCz
PAGE 1463
Enzymes transmit information that turns cellular functions ON andOFF. Is it possible to use themechanisms of regulation of enzymes
for the development of medicines to turn enzymes ON or OFF for treatment of human diseases? Lopez-Garcia et al. build on previ-
ously developed small compounds that target a site (termed ‘‘PIF-pocket’’) on a protein kinase and activate the enzyme, and describe
reversible compounds that binding to the PIF-pocket of PKCz inhibit the enzymatic activity. Thus, the PIF-pocket is a switch that can
be targeted with drugs to turn these enzymes ON or OFF.Inhibit Autophagy by Breaking the Mitochondrial Chain
PAGE 1474
Autophagy is a cellular lysosome-dependent catabolic mechanism mediating the turnover of intracellular organelles and long-lived
proteins. Here Ma et al. show that antimycin A, a known inhibitor of mitochondrial electron transport chain (mETC) complex III,
can inhibit autophagy through its inhibitory activity on mETC complex III. Therefore, mETC complex III may have a role in mediating
autophagy induction.Take a Look at the Carrier
PAGE 1482
The common metabolites, fatty acids, polyketides, and nonribosomal peptides, are all synthesized by
complex enzyme machines using small carrier domains to traffic and activate building blocks. The carrier
domain is a dynamic component of the process, shuttling pathway intermediates to enzyme active sites.
Here Liu et al. report an approach to structurally fix carrier domains suitable for structural analysis. As an
example, the structure of a two-domain construct was determined with a mechanism-based inhibitor.Chemistry & Biology 18, November 23, 2011 ª2011 Elsevier Ltd All rights reserved vii
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Gloriam et al. describe a pioneering chemogenomic ligand inference between families of G protein-coupled receptors, a major drug
target class. This proof-of-concept expands the prospects of successful drug design and discovery. It resulted in the discovery of
ligands with allosteric antagonistic activity at GPRC6A, a receptor recently indicated to have a role in metabolism. These ligands
constitute useful research tools towards investigating the signalingmechanism of theGPRC6A receptor at the cellular level and serve
as initial lead compounds for further optimization of potency and selectivity enabling future ex vivo/in vivo pharmacological studies.
Single Cluster, Two Natural Products
PAGE 1499
Indole alkaloid cluster in P. chrysogenum is responsible for the production of roquefortine C, glandicolines, andmeleagrin, all derived
from cyclo-L-His-L-Trp by modification reactions. Now, Garcia-Estrada et al. deduce the functions of the modifying enzymes using
knockdown mutants; for example, they show that a prenyltransferase catalyses the reverse prenylation in R-configuration in carbon
3-position of the diketopiperazine, followed by ring closure between C2 and N12. Two oxidoreductases and one cytochrome P450
oxygenase are involved in hydroxylations and dehydrations of the pathway intermediates, and one N-OHmethyltransferase leads to
meleagrin.viii Chemistry & Biology 18, November 23, 2011 ª2011 Elsevier Ltd All rights reserved
